BOULDER, Colo., Jan. 23, 2020 (GLOBE NEWSWIRE) — miRagen Therapeutics Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, today announced that it will present new...
PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that both batches of the company’s manufactured...
— Phase 3 trial achieved its primary endpoint and all secondary endpoints with marked improvement in key indicators of disease — January 22, 2020 05:20 PM Eastern Standard Time DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP)...
NEW YORK, Jan. 22, 2020 /PRNewswire/ — By definition, an email drip campaign is a type of marketing process that entails the automated dissemination of emails. In addition to the ability to personalize messages, a drip campaign can be set to run during a...
TEL AVIV, Israel, Jan. 22, 2020 /PRNewswire/ — BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today the completion of patient recruitment in the triple combination arm of its ongoing Phase 2a...
VANCOUVER, Jan. 22, 2020 /CNW/ – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) announces that the final toxicology test, a Human Repeated Insult Patch Test (“HRIPT”), has successfully been completed. Sirona is...
Email
Text